Yumei Diao
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Efficacy of melflufen in multiple myeloma with mutated or deleted TP53.
Journal: Experimental hematology & oncology
Published: August 11, 2025
An Anti-BCMA Affibody Affinity Protein for Therapeutic and Diagnostic Use in Multiple Myeloma.
Journal: International journal of molecular sciences
Published: May 12, 2025
Affibody-based hBCMA x CD16 dual engagers for NK cell-mediated killing of multiple myeloma cells.
Journal: New biotechnology
Published: July 04, 2023
A rapid intracellular enrichment of alkylating payload is essential for melphalan flufenamide potency and mechanism of action.
Journal: Biochemical and biophysical research communications
Published: February 10, 2023
Identification of novel GLI1 target genes and regulatory circuits in human cancer cells.
Journal: Molecular oncology
Published: April 26, 2018
The impact of S6K1 kinase on neuroblastoma cell proliferation is independent of GLI1 signaling.
Journal: BMC cancer
Published: May 07, 2014
Identification of novel non-coding RNA-based negative feedback regulating the expression of the oncogenic transcription factor GLI1.
Journal: Molecular oncology
Published: November 16, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026